Lakeshore Biopharma Co Ltd's Comment on Supply Chain
The company procures raw materials, packaging materials, testing reagents, instruments, finished goods, and consumables for vaccine development. Inventory levels are maintained at three to six months for raw materials, one to two months for packaging materials, and six to 12 months for imported raw materials. Finished product inventory is typically targeted at four to six months but increased to over 12 months in fiscal year 2025 due to industry policy adjustments and market dynamics. The company employs an inventory management system compliant with GMP regulations to monitor inventory stages, balances, and validity. Warehouses at manufacturing facilities include inspection and post-inspection areas, managed by trained personnel responsible for storage and distribution. To enhance logistics, the company operates a centralized warehouse in Shenyang and 25 satellite transition warehouses across China as of March 31, 2025. Manufacturing and product quality are overseen by a comprehensive GMP-compliant quality management system, with separate quality assurance and quality control teams, as well as a validation team for machinery and processes.
Lakeshore Biopharma Co Ltd's Comment on Supply Chain
The company procures raw materials, packaging materials, testing reagents, instruments, finished goods, and consumables for vaccine development. Inventory levels are maintained at three to six months for raw materials, one to two months for packaging materials, and six to 12 months for imported raw materials. Finished product inventory is typically targeted at four to six months but increased to over 12 months in fiscal year 2025 due to industry policy adjustments and market dynamics. The company employs an inventory management system compliant with GMP regulations to monitor inventory stages, balances, and validity. Warehouses at manufacturing facilities include inspection and post-inspection areas, managed by trained personnel responsible for storage and distribution. To enhance logistics, the company operates a centralized warehouse in Shenyang and 25 satellite transition warehouses across China as of March 31, 2025. Manufacturing and product quality are overseen by a comprehensive GMP-compliant quality management system, with separate quality assurance and quality control teams, as well as a validation team for machinery and processes.
Sources:
Lakeshore Biopharma Co Ltd's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Lakeshore Biopharma Co Ltd’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
